About Us
Medical Blog
  • Smith & Nephew, Arthrex Settled Suture Anchor Patent Dispute Before Trial

    On February 14, 2017, U.S. District Judge Michael Mosman of the United States District Court, District of Oregon granted a Joint Stipulated Motion for Dismissal with Prejudice submitted by Plaintiffs Smith & Nephew, Inc. and John O. Hayhurst, M.D. (inventor) and Defendant Arthrex, Inc. subject to the terms of a Settlement and License Agreement.  Information about the settlement terms is not ...
  • Biogen to Pay Forward $1.25 Billion in Settlement

    Forward Pharma A/S ("Forward") recently announced that a necessary super majority of its shareholders have approved a settlement of various patent disputes with two wholly-owned subsidiaries of Biogen Inc. ("Biogen") in which Forward will receive USD $1.25 billion cash from Biogen.  77% of the voting shareholders voted in favor of accepting the settlement agreement. Founded in 2005, Forward, a ...
  • New Video Resources on Inter Partes Review (IPRs)

    Since 2012, Inter Partes Review ("IPR") has emerged as one of the most significant new procedures in patent law. An IPR is a proceeding in the Patent Office, and allows a party to challenge an issued patent on certain prior art grounds.  If successful, the challenging party can invalidate some or all of the patent claims. IPRs can be an alternative to challenging a patent in court, although oft ...
Conferences